Johnson & Johnson’s single-shot COVID-19 vaccine will begin shipping in the U.S. on Monday morning, marking the third shot in the country’s arsenal after a greenlight from the FDA and a panel with the Centers for Disease Control and Prevention.
Johnson & Johnson’s single-shot COVID-19 vaccine will begin shipping in the U.S. on Monday morning, marking the third shot in the country’s arsenal after a greenlight from the FDA and a panel with the Centers for Disease Control and Prevention.
